What You Should Know:
– GE HealthCare announced today that its MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a groundbreaking tool in the fight against Alzheimer’s disease.
–…
Continue Reading
What You Should Know:
– Eli Lilly’s Kisunla™ (donanemab-azbt) has been approved by the FDA as a treatment for adults in the early stages of Alzheimer’s disease (AD), including those with mild cognitive impairment (MCI)…
Continue Reading
What You Should Know:
– ALZpath, a leader in Alzheimer’s disease diagnostics, announced a licensing agreement with Roche for their innovative pTau217 antibody. This paves the way for a blood test to diagnose Alzheimer’s disease…
Continue Reading
National University Hospital testing Alzheimer’s predictive AI from KoreaSingapore’s National University Hospital is collaborating with medical AI company Heuron from South Korea to test the latter’s AI solutions for screening and predicting Alzheimer’s disease.
Heuron…
An initiative that uses interactive light technology to develop activities and games for people with dementia has been rolled out by the Alzheimer’s Society in partnership with Sport England and Social-Ability.The Happiness Programme, developed…
Continue Reading
By Shania Kennedy
May 03, 2024 – A team of researchers from Cleveland Clinic found that machine learning can help characterize how gut microbial metabolites and cell receptors interact to influence Alzheimer’s disease, according to a…
Continue Reading
By Shania Kennedy
February 29, 2024 – Researchers at the Icahn School of Medicine at Mount Sinai have developed machine learning (ML) models to identify mortality predictors in dementia patients, according to a study published this…
Continue Reading
The UK government has made a multi-million pound investment in potential breakthrough medical devices. As part of a £10 million funding package for boosting access to medical technology, eight innovative tech companies will be supported…
Continue Reading
Neurophet AI to integrate with upcoming Alzheimer’s treatment deviceNeurophet has entered into a partnership with ReadyCure for the development of a dementia treatment system called Helaxon.
Based on a press statement, Neurophet will be integrating its…
By Shania Kennedy
February 02, 2024 – Researchers from the University of Texas at Arlington (UTA) have developed a model to predict how a patient’s Alzheimer’s will progress over time, according to a study published recently…
Continue Reading
